Although less sedation will work well on appropriately selected patients who need to have simple diagnostic testing, be aware that this approach can be associated with increased cardiac stress. In a recent study, Adachi found that upper endoscopy, without sedation, increased cardiac stress, when measured as the rate-pressure product by more than 66% [2•]. The level of stress approximates 3.3 metabolic equivalents of treadmill exercise. Therefore, sedationless procedures can entail increased risks. In those cases where decreased levels of sedation are desired, other options should be considered. One such option is the use of benzodiazepines without narcotics. In a randomized trial, LaLuna et al. found no difference in intubation time, procedure time, blood pressure, or patient procedure recall in those who received narcotics and benzodiazepines (n = 53) compared with those who received only benzodiazepines (n = 54) [3] . When benzodiazepines are to be used without narcotics, consider the addition of local anesthetics (lidocaine) to benzodiazepines. In a randomized, double-blind, placebo-controlled, prospective trial of 200 patients, Froehlich et al. demonstrated that the administration of local anesthetics to those receiving only midazolam improved patient procedure tolerance [4] .
When deeper sedation is needed, studies have described the safe use of droperidol (Inapsine, Janssen Pharmaceutica, Toronto, Ontario, Canada) in conjunction with benzodiazepines and narcotics [5] . However, in selected cases, droperidol has been associated with cardiac toxicity. Therefore, alternative drugs have been sought to replace it. Propofol (Diprivan, Astra Zeneca, Wilmington, DE) is an intravenous sedative hypnotic with analgesic effects, which is thought to be a highly effective replacement. In a prospective, nonrandomized study, comparing the effect of propofol and fentanyl (n = 150) with meperidine (Demerol, Abbott Laboratories, North Chicago, IL) and midazolam (Versed, Roche Pharmaceuticals, Nutley, NJ) (n = 124), Koshy et al. reported that propofol and fentanyl provided a twofold increase in patient comfort compared with the control group of meperidine and midazolam (95% CI 1.05-3.923), while maintaining a significantly shorter recovery time [6] . Furthermore, propofol seems to have an excellent safety profile. In the largest published gastrointestinal (GI) series to date, Rex et al. demonstrated a 0.002% (5/2222) rate of adverse events, all of which were minor [7•]. The minor adverse events consisted of five episodes of mild respiratory depression that responded to stopping the propofol drip and placing a 100% oxygen mask without the need for intubation. This excellent safety profile can be increased even further through the use of automated graphic assessment devices and capnographs (Marquette Direct Digital Writer, Series 7160, Marquette Medical Systems, Marquette, MI). These devices are monitors that give rise to a wider safety margin, by providing earlier signs of respiratory depression than even pulse oximeters [8] . Finally, studies have shown that propofol may not need to be administered by nurse anesthetists. Recent studies have demonstrated its safe administration by a GI nurse, under the supervision of a GI physician [9,10].
Infection control
In the era of viral hepatitis and the human immunodeficiency virus, another crucial topic in the field of gastric interventional endoscopy is infection control. Data have shown that if current reprocessing guidelines are followed, this risk is minuscule-about 1 in 1.8 million [11] . Unfortunately, the reprocessing guidelines may not always be followed. In a recent Spanish study, questionnaires to GI endoscopists demonstrated that because of inadequate funding and facilities in rural parts of the country, up to 23% of the facilities lack automated reprocessors [12] . Every gastroenterologist, here and elsewhere, must understand and adhere to the reprocessing guidelines to prevent transmission of infection. These guidelines are well summarized in a recent report [11] . Briefly, they require:
Mechanical cleansing and running of all exposed internal and external surface under water Use of an effective liquid chemical germicide (LCG) for high level disinfection, with the complete immersion of the endoscope into automatic washes Rinsing the scope under water to minimize chemical toxicity Drying the scope and storing it in a dry and clean environment
Interventional endoscopy techniques
A wide variety of interventional endoscopic techniques are used in the stomach. These include hemostasis, endosonography (EUS), endoscopic mucosal resection (EMR), stenting, and percutaneous endoscopic gastrotomy (PEG) tube placement. We review how these techniques should be performed, discuss their efficacy and safety data, and use that information in an evidencebased-medicine approach to make recommendations regarding how each of these techniques can fit into the day-to-day patient management algorithms.
Hemostasis Technology
In this review, hemostasis is used to refer to any process aimed at the cessation of bleeding. It can be accomplished through the use of a number of hemostatic devices, including thermal devices (heater probes and argon plasma coagulators), injection devices, and mechanical devices (band ligators and hemoclips) [13, 14] . The most appropriate technique and device to use in promoting hemostasis varies according to the specific circumstances.
Peptic ulcer disease Bleeding caused by peptic ulcer disease is best approached with a combination therapy technique using injection therapy to tamponade and heat therapy to coapt the bleeding vessel. Using this approach on patients with spurting blood vessels, Chung et al. demonstrated a significant reduction in rebleeding rate and in need for both emergency surgery and blood transfusions, compared with the use of the heater probe as a single modality therapy [15] . Attempts at improving these results by removing epinephrine from the injectant or adding fibrin glue have met with little success [16, 17] . However, the use of larger volume of injectants seems to offer a better outcome. Lin showed that the use of large volume epinephrine injectant (16.6 mL/patient; 15.7-17.3 mL) decreased the rebleeding rate from 31% (24/78) in the control population (8 mL/patient; 7.5-8.4 mL) to 15% (12/78: P < 0.037) [18] . However, the study only examined single modality therapy. Therefore, before widespread use of this technique can be recommended, its impact in the setting of combination therapy, which is the current standard of care, must first be evaluated.
When combination therapy fails or when patients have an incorrectable coagulopathy, mechanical devices should be considered. Hemoclips (Olympus Optical Co., Ltd., Tokyo, Japan) are of particular interest because they permit treatment of the problem directly by allowing clips to be placed on the bleeding vessels endoscopically (Fig. 1) . Although preliminary data support the use of these mechanical devices to promote hemostasis, the results have been inconsistent [19] [20] [21] . In a small study by Gevers, patients who had hemoclips placed on bleeding vessels had a higher incidence of rebleeding (13/35; 37%) compared with those who had injection therapy (5/34; 15%) or those who received injection therapy in addition to hemocliping (8/32; 25%) [21] . However, this study suffered from a number of flaws: (1) small sample size, (2) high rebleeding rate even in the control group, and (3) confounding variables, such as the expertise of the endoscopic team, were not properly evaluated. Until larger studies with sufficient power and better design are available, mechanical devices should continue to be considered as second-line therapy for hemostasis.
Dieulafoy lesions and Mallory-Weiss tears
When Dieulafoy lesions and Mallory-Weiss tears cause GI bleeding, the management strategies have not been clear because the data have been so sparse. Recent studies suggest that these types of lesions can be approached in the same fashion as those in patients bleeding from peptic ulcer disease vessels, with similar outcome [22] [23] [24] .
Varices Bleeding resulting from gastric varices is treated with single modality therapy: banding [25] . However, banding of gastric varices can be associated with a significant rebleeding rate. Therefore, a search for alternative modalities continues. In an animal model, the injection of 2-octyl-cyanoacrylate (Dermabond, Ethicon Inc., Somerville, NJ) into the auricular veins of New Zealand white rabbits promoted hemostasis [26] . However, its injection into patients with bleeding gastric varices has also been shown to be associated with transient bacteremia. In a controlled study of patients bleeding from gastric varices, Chen demonstrated a higher incidence of transient bacteremia (15/47) in patients injected with Dermabond compared with their control counterparts (1/47) [27] . Because this agent is not yet approved for use in the United States, banding remains the standard of care in treating patients bleeding from gastric varices. However, when it does get approved, empiric antibiotic coverage should be considered with its use.
Appropriate management of patients with upper GI bleeding does not end with establishing hemostasis. Patient disposition and pharmacologic therapy are integral management components.
Disposition
Over the years, a number of clinical scoring systems have been developed to help differentiate between patients at high risk for rebleeding and, therefore, require in-house observation from those at low risk who not at risk for rebleeding and, therefore, can be safely discharged [28] . Of these, the Rockall scoring system has been the most useful. Based on this system, each patient gets an overall score that is the sum of two scores: a clinical score and an endoscopic score. The clinical score is based on the patient's age, hemodynamic stability, and any comorbidity. The endoscopic score is based on the patient's diagnosis and the presence or absence of stigmata of bleeding. When the scores are combined, a cutoff value of 7 seems to differentiate bleeders at high risk from those at low risk. Church and Palmer recently confirmed the clinical importance of this score [29] . In their study, they found that patients with a score less than 7 (n = 155) had a rebleeding rate of 12% and a mortality rate of 10%. On the other hand, those with a score of more than 7 (n = 56) had a rebleeding rate of 29% and a mortality rate of 25%. The differences between these two groups of patients were clinically and statistically significant (P < 0.004). Therefore, using the Rockall score, those patients found to have a low score (<7) could be safely discharged, whereas those with higher scores would deserve close in-house observation.
Pharmacologic therapy
Acid suppressive therapy Although a controversial topic for many years, patients at high risk for rebleeding will likely benefit from acid suppressive therapy through the use of proton pump inhibitors, according to a recent study [30] . These findings were confirmed recently in a large, welldesigned, placebo-controlled, prospective, randomized trial by Lau et al. [31] . In his study, the use of intravenous (iv) proton pump inhibitors (20-mg iv bolus followed by 60 mg/72 h) significantly decreased the rebleeding rate from 23% to 7% (P < 0.001). Higher doses of protonpump inhibitors (80-mg iv followed by 652 mg/72 h) did not significantly change the outcome [32] . Therefore, the use of iv proton pump inhibitors should be considered, following endoscopic therapy in patients at high risk for rebleeding. [34, 35] . Therefore, in this group of patients, assessing H. pylori status seems to be better through the use of serologies or the breath test rather than the conventional RUT. In 78 patients with upper GI bleeding, known to harbor H. pylori, Grino et al. showed that serologic testing and breath analysis was far superior in detecting the presence of the bacterium than the conventional RUT with sensitivity and specificity results of 89.5/80, 91/77.8, and 48.5/100, respectively [36] .
Nonsteriodial antiinflammatory drugs Long-term proton pump inhibitor therapy is indicated in patients with nonsteroidial antiinflammatory drugs (NSAID)-induced ulcer requiring continued use of NSAID. Lai et al. demonstrated that, following ulcer healing, the use proton pump inhibitors significantly decreased the incidence of ulcer recurrence and complications from 14.8% (9/61) to 1.6% (1/62) [37••] . Early studies seem to indicate that patients on selective cox-2 NSAID, such as rofecoxib (Vioxx, Merck, Whitehouse Station, NJ) and celecoxib (Celebrex, Pharmacia, Skokie, IL), may not be at high risk for rebleeding [38, 39] .
Endosonography
Endosonography is a unique technology that combines the science of ultrasound with the technology of the endoscope, giving rise to detailed images of the GI wall and its neighboring structures that cannot be obtained in any other way [40••] . As such, it has become a tool that is crucial in the evaluation of a number of gastric disorders including, but not limited to, gastric cancer, gastric submucosal lesions, and thickened gastric wall syndromes.
Gastric cancer
Gastric cancer treatment is stage dependent. Early disease is treated with surgical resection, whereas locally advanced, nonmetastatic disease is treated with multimodality therapy [40••] . Currently, endosonography is the only way preoperatively to differentiate between early and locally advanced disease. In a meta-analysis of 13 studies from the literature, Kelly et al. found EUS staging to be highly accurate, with a sensitivity of 68 % to 100% and a specificity of 88% to 100% [41] . Therefore, patients with gastric cancer, who have no metastatic disease seen on computed tomography scan, must have endosonography to distinguish those patients with locally advanced disease who will need adjuvant therapy before surgery from those with early disease who would not.
Gastric submucosal lesions
Gastric submucosal lesion is a generic endoscopic description given to one of a variety of pathologic tumors that may develop in the stomach. 
Gastric thickened fold syndromes
Thickened gastric fold syndromes can be caused by a number of different conditions, including, but not limited to, portal hypertension, mucosa associated lymphoid tissues (MALTomas), and lymphomas [40••] . Studies have demonstrated that endosonography is a modality uniquely suited to differentiate between these entities with a relatively high degree of accuracy [43, 44] . However, interobserver variation was noted in the evaluation of some of these syndromes, most notably the MALTomas [45] . Most endosonographers believe that this does not demonstrate a weakness in the technology, but rather the lack of objective guidelines and objective criteria available to evaluate these conditions. Until such guidelines and criteria do become available, use caution when interpreting endosonographic data from patients with these syndromes.
Endoscopic mucosal resection
Endoscopic mucosal resection (EMR) is an advanced endoscopic technique used to cure early types of gastric cancer [46] . It can be performed in a variety of ways. The most common method is the "suction-cap" technique (Fig. 2) . Through this technique, saline is injected submucosally to form a cushion between the mucosal lesion and the muscularis propria. Subsequently, the cap (MAJ297, Olympus America, Inc., Melville, NY) is attached to the tip of the scope and placed on the lesion. With the application of suction, the lesion is pulled into the lumen of the cap. The lesion is then ensnared and resected with electrocautery. In expert hands, the technique is efficacious and safe. Although somewhat incomplete, data from three large series in the literature, comprised of 1061 cases, demonstrate a 5-year survival of 85%, a 10-year survival of 84%, and a complication rate of 4% (Table 1 ) [47-49•] . Recently, this technique has been safely used to remove ampullary neoplasms (n = 5) as well as duplication cysts [50, 51] .
Gastroduodenal stenting
Stenting of malignant, unresectable gastroduodenal obstruction is another new technique that continues to undergo technologic development [52] . The technique has gained popularity over the past few years as a result of improvements in expandable metal stents [53] . The technique is simple (Fig. 3) . The scope is placed at the proximal part of the gastroduodenal narrowing. An injection catheter, under fluoroscopy, is threaded through the area of narrowing and used to mark the distal part of the obstruction by injecting contrast medium submucosally. The injection catheter is then withdrawn proximally and used to inject contrast medium, submucosally marking the proximal margin of the tumor. The length of the obstruction is then measured using fluoroscopic guidance and an appropriate size enteral stent (Boston Scientific Microvasive Endoscopy, Inc., Natick, MA) is chosen. The stent is passed through the channel of the scope and advanced through the area of narrowing using the through-the-scope technique. Under fluoroscopic and endoscopic guidance, the stent is slowly deployed in a distal to proximal fashion. In expert hands, the efficacy of gastroduodenal stenting has been well described in the literature. The two largest published series (together composed of 60 patients) report a combined success rate of 91.7% (55/60), successful palliation in 81% to 90% of the cases, and a complication rate of 10% (Table 2) [54•, 55•]. In selected patients, this has become the method of choice for palliating unresectable, malignant gastroduodenal obstruction.
Percutaneous gastrostomy tube placement
When the gut can be used for nutrition, PEG placement continues to be the best way to access it for long-term use [56] . New information regarding its indications, contraindications, and follow-up care continue to accumulate and warrant reviewing.
Indications
Currently, PEG tube placement is recommended in malnourished patients who have difficulty swallowing because of a number of conditions. These include, but are not limited to, head and neck cancer, esophageal cancer, and certain types of neurologic disorders that are associated with oropharyngeal dysfunction (eg, cerebrovascular accidents, Parkinson's disease) [56] . Occasionally, its use 
Followup
Although thought to be a benign procedure, a recent single center series demonstrated that PEG tube placement can be associated with complications in 22% (57/263) of patients. These vary from minor complications (eg, leakage at the site of the bumper) to major ones (eg, bumper migration, peritonitis, and bleeding) [63] . Therefore, once a PEG tube is placed, it is crucial that patients are followed on a regular basis to look for and prevent these complications, whenever possible. 
Conclusions: future directions
Despite the advances to date in the field of interventional endoscopy, more needs to be done to improve patient comfort, diagnostic accuracy, and therapeutic efficacy. 
